IR820-PTX [2250419-19-1]

MedChem Express

IR820-PTX [2250419-19-1]

5

2250419-19-1

Research Use Only

C99H112N4NaO21S2+

1781.08

IR820-PTX, an IR-820 (HY-136886)-Paclitaxel (HY-B0015) conjugate, is an amphipathic small molecule prodrug. IR820-PTX effectively inhibits tumor growth via combined photothermal therapy (PTT) and chemotherapy[1][2].

CC(O[C@]12[C@@]3([H])[C@@H]([C@]4(C(C)(C([C@H](C([C@@]3([C@H](C[C@@]1([H])OC2)O)C)=O)OC(C)=O)=C([C@H](C4)OC([C@H](OC(CCCCCNC5=C(/C=C/C6=[N+](C7=C(C8=CC=CC=C8C=C7)C6(C)C)CCCCS(=O)(O[Na])=O)CCC/C5=C\C=C9N(C%10=C(C%11=CC=CC=C%11C=C%10)C\9(C)C)CCCCS(=O)(O)=O)=O)[C@H](C%12=CC=CC=C%12)NC(C%13=CC=CC=C%13)=O)=O)C)C)O)OC(C%14=CC=CC=C%14)=O)=O

12162000